Related references
Note: Only part of the references are listed.When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives
Paraskevi Apostolou et al.
CANCER GENETICS (2021)
Current perspectives on CHEK2 mutations in breast cancer
Panagiotis Apostolou et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Biology of breast cancer during pregnancy using genomic profiling
Hatem A. Azim et al.
ENDOCRINE-RELATED CANCER (2014)
Breast cancer in young women: special considerations in multidisciplinary care
Chantal Reyna et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2014)
Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer
Tomasz Huzarski et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Anthony Renwick et al.
NATURE GENETICS (2006)
Share Paper
